Multiple sclerosis (MS) is a disease in which your immune system attacks the protective sheath (myelin) that covers your nerves. Myelin damage disrupts communication between your brain and the rest of your body. Ultimately, the nerves themselves may deteriorate, a process that’s currently irreversible. Signs and symptoms vary widely, depending on the amount of damage and which nerves are affected. Some people with severe MS may lose the ability to walk independently or at all, while others experience long periods of remission during which they develop no new symptoms.
There’s no cure for multiple sclerosis. Treatment typically focuses on speeding recovery from attacks, slowing the progression of the disease and managing symptoms. Some people have such mild symptoms that no treatment is necessary.
Currently prescribed medications include Anti-inflammatory drugs to reduce inflammation, Plasma exchange (plasmapheresis), Beta interferons, and immuno-suppressants to get the immune response back under control and pain medication. Like all existing treatment there are significant side effects to the treatments many side effects from meds – flu like symptoms, injection site reactions, elevated liver functions, allergic reactions, increase likelihood of infections etc.
Clinical trials clearly illustrate that LDN is a relatively safe therapeutic option in RRMS and SPMS but it is now important to complete a Phase II/. III trial, AS LDN would be one of the few non-toxic treatments for MS.